Injection, casirivimab and imdevimab, 1200 mg
Code effective Dec 13, 2024
HCPCS Section
Miscellaneous Services (Temporary Codes)
Q0244 is a valid 2026 HCPCS code meaning Injection, casirivimab and imdevimab, 1200 mg or (Casirivi and imdevi 1200 mg) for short. HCPCS Q0244 has been effective since 12/13/2024 and applies to Pneumococcal/flu vaccine.
|
HCPCS Level II Code Section Q - Miscellaneous Services (Temporary Codes) |
|
| HCPCS Code | Q0244 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
54 - Vaccinations
|
| Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
| Coverage code | C - Carrier judgment |
| BETOS2 code | O1G - Immunizations/Vaccinations |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | V - Pneumococcal/flu vaccine |
| Effective date | Effective Dec 13, 2024 |
| Date added | Added Jun 03, 2021 |
| Termination date | Dec 12, 2024 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.